Tirzepatide side effects: what the label lists

The side effects on the Mounjaro® and Zepbound® labels, why they cluster around dose increases, the serious warnings, the birth-control note, and when to call.

Tirzepatide is the active ingredient in Mounjaro® and Zepbound®, and in the compounded tirzepatide GLP's clinicians prescribe. This article restates what the FDA-approved labels list as side effects and warnings, explains the pattern most people notice, and says when to contact a clinician. It is not a substitute for the medication guide that comes with a prescription.

What are the most common tirzepatide side effects?

The Zepbound® label lists these as the most common: nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection-site reactions, fatigue, hypersensitivity reactions, burping, hair loss and heartburn. The Mounjaro® label's list is similar and adds reduced appetite. Almost all of them are gastrointestinal, and most are described as mild to moderate.

Why do side effects cluster around dose increases?

Tirzepatide slows how quickly the stomach empties and acts on appetite signals; the body adjusts to each dose over weeks. Side effects are reported most in the first weeks and after each 2.5 mg step, which is why the label starts everyone at 2.5 mg and holds each step for at least four weeks. A prescriber can keep someone at a step longer, or go back one, when the current dose is not being tolerated.

What helps with nausea and stomach upset?

• Smaller portions, eaten slowly, and stopping when full rather than when the plate is empty.
• Bland, low-fat food on the days after an injection, and noticing which foods sit badly.
• Fluids across the day; vomiting and diarrhea can dehydrate, which is one of the ways kidney problems arise on the label.
• Telling your care team early. Holding a dose step is routine; suffering through one is not required.

What are the serious warnings?

Both labels carry a boxed warning about thyroid C-cell tumors seen in animal studies, and contraindicate tirzepatide in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. The warnings sections cover acute pancreatitis, acute gallbladder disease, low blood sugar when combined with insulin or sulfonylureas, serious allergic reactions, acute kidney injury linked to dehydration, severe gastrointestinal disease, complications of diabetic retinopathy, and pulmonary aspiration during general anesthesia or deep sedation, which is why patients are told to tell anyone sedating them that they take it. The Zepbound® label also advises monitoring for depression or suicidal thoughts.

Does tirzepatide affect birth control?

Yes, per the labels. Because tirzepatide slows stomach emptying, it can reduce how well oral hormonal contraceptives are absorbed. The labels advise switching to a non-oral method, or adding a barrier method, for four weeks after starting treatment and for four weeks after each dose increase. Tell your clinician everything you take.

Who should not take tirzepatide?

Anyone with the contraindications above, anyone who has had a serious allergic reaction to it, and anyone who is pregnant, planning a pregnancy or breastfeeding. A history of pancreatitis or gallbladder disease, significant gastrointestinal conditions, type 1 diabetes, and medications that affect blood sugar all call for a clinician's judgment.

When should I contact a clinician?

Promptly, for severe or persistent abdominal pain (with or without vomiting, sometimes felt in the back), signs of gallbladder trouble such as pain in the upper right abdomen or yellowing skin, vomiting that will not stop, signs of dehydration, vision changes, a fast heartbeat, or a lump or hoarseness in the neck. For swelling of the face or throat, trouble breathing, or any medical emergency, call 911. For anything else that concerns you, message your care team; adjusting a plan is routine.

Are compounded tirzepatide's side effects the same?

The active ingredient is the same, so the same warnings apply. Compounded tirzepatide is prepared by a licensed compounding pharmacy for an individual patient. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Report anything unexpected to your care team.

This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.